Experiments for taxon Boswellia carteri (BURSERACEAE)

187 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
708428	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Boswellia carteri (BURSERACEAE)
369946	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Boswellia carteri (BURSERACEAE)
932222	ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
1320024	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIOXYTOCIC EFFECT	Boswellia carteri (BURSERACEAE)
468634	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	LIMONENE
284885	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE,5: INHIBITION	Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 9-11-DEHYDRO:
554291	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HIV) INHIBITION	Boswellia carteri (BURSERACEAE)
593577	MEDICINAL FOLKLORE REPORTED FOR	ANTITUSSIVE ACTIVITY	Boswellia carteri (BURSERACEAE)
468637	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CARYOPHYLLENE,BETA:
353648	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
848373	UV SPECTRUM GIVEN FORGC DATA REPORTEDPMR SPECTRUM REPORTEDHPLC DATA REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL-11-KETO:
870253	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINENE,ALPHA:
639196	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Boswellia carteri (BURSERACEAE)
756001	PHARMACOLOGY OF EXTRACT - IN VITRO	LEUKOTRIENE B4 RELEASE ENHANCEMENT	Boswellia carteri (BURSERACEAE)
779665	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Boswellia carteri (BURSERACEAE)
1319929	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
73356	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
530356	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIAMEBIC ACTIVITY	Boswellia carteri (BURSERACEAE)
932221	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
665587	PHARMACOLOGY OF EXTRACT - IN VIVO	NUCLEOSIDE TRANSPORT INHIBITION	Boswellia carteri (BURSERACEAE)
870242	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CINEOL,1-8:
468631	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PINENE,ALPHA:
870263	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	HEXYL OCTANOATE
870247	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	MYRCENE
599887	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Boswellia carteri (BURSERACEAE)
353649	PHARMACOLOGY OF EXTRACT - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Boswellia carteri (BURSERACEAE)
870269	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	DECAN-1-OL
943093	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Boswellia carteri (BURSERACEAE)
665589	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL-11-KETO:
870236	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
77019	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
870270	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	OCTAN-1-OL ACETATE
1147591	MEDICINAL FOLKLORE REPORTED FOR	ANTICOAGULANT ACTIVITY	Boswellia carteri (BURSERACEAE)
870231	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CITRONELLOL ACETATE
21015	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
1214351	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Boswellia carteri (BURSERACEAE)
299201	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA:
1116318	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
1318404	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
1306374	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	NITRIC OXIDE SUPPRESSION	Boswellia carteri (BURSERACEAE)
284881	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 3-O-ACETYL-11-METHOXY:
1320020	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
870258	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	OCIMENE,BETA: TRANS:
593578	MEDICINAL FOLKLORE REPORTED FOR	COSMETIC EFFECTS	Boswellia carteri (BURSERACEAE)
870252	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	SABINENE
1116316	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
1318505	TRADITIONAL MEDICINEPHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOREFFECTS DUE TO A COMBINATION OF DRUGS	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
708427	PHARMACOLOGY OF EXTRACT - IN VITRO	SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)	Boswellia carteri (BURSERACEAE)
299197	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL-11-KETO:
1320019	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
713110	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Boswellia carteri (BURSERACEAE)
848371	GC DATA REPORTEDPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,ALPHA: ACETYL:
495321	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	LIMONENE
1306373	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	MENTH-4-EN,PARA-1,2-DIOL:SOBREROL,TRANS: (-):MENTH-1-EN,PARA-3,6-DIHYDROXY:MENTH-5-EN,PARA-1,2-DIOL:FOUQUIEROL,ISO:LUPEOL,EPI:MENTH-1-EN,PARA-4-ALPHA,6-BETA-DIOL:
299198	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Boswellia carteri (BURSERACEAE)	LUP-20(29)-EN-24-OIC ACID,3-ALPHA-ACETOXY:
639195	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
284884	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 9-11-DEHYDRO:
870262	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CEMBRENE,ISO:
870237	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
604661	MEDICINAL FOLKLORE REPORTED FOR	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
468636	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	BOURBONENE,BETA:
284879	ISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 3-O-ACETYL-11-HYDROXY:
848374	UV SPECTRUM GIVEN FORGC DATA REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA:
77020	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
74928	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	SELINA-5-7(11)-DIENEMENTHA-1-4-DIEN-8-OL,PARA:
369948	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Boswellia carteri (BURSERACEAE)
353650	PHARMACOLOGY OF EXTRACT - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Boswellia carteri (BURSERACEAE)
870266	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	ANISOLE,O-METHYL:
870248	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	NEROL ACETATE
21016	MEDICINAL FOLKLORE REPORTED FOR	CNS DEPRESSANT ACTIVITY	Boswellia carteri (BURSERACEAE)
702075	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HEPATITIS C VIRUS) INHIBITION	Boswellia carteri (BURSERACEAE)
468629	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CYMENE,PARA:
16824	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	INCENSOLE
870241	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CAMPHENE
870259	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	INCENSOLE
1116317	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
870240	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	BORNEOL ACETATE
1320021	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
1318405	PHARMACOLOGY OF EXTRACT - IN VIVO	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
21013	MEDICINAL FOLKLORE REPORTED FOR	ANTISCHISTOSOMAL ACTIVITY	Boswellia carteri (BURSERACEAE)
284880	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 3-O-ACETYL-11-METHOXY:
369947	PHARMACOLOGY OF EXTRACT - IN VITRO	ORNITHINE DECARBOXYLASE INHIBITION	Boswellia carteri (BURSERACEAE)
495322	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CYMENE,PARA:
1306372	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	OLIBANUMOL JOLIBANUMOL BOLIBANUMOL COLIBANUMOL AOLIBANUMOL HOLIBANUMOL I
1320022	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
870234	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
914507	IDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: O-ACETYL:BOSWELLIC ACID,BETA:
384814	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
870261	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CEMBRENE
870245	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	LIMONENE
468628	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CARYOPHYLLENE OXIDE
870255	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINEN-4-OL
639198	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Boswellia carteri (BURSERACEAE)
468632	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	THUJENE,ALPHA:
1190713	MEDICINAL FOLKLORE REPORTED FOR	ESCHAROTIC EFFECT	Boswellia carteri (BURSERACEAE)
403176	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIYEAST ACTIVITY	Boswellia carteri (BURSERACEAE)
1292441	MEDICINAL FOLKLORE REPORTED FOR	EMETIC ACTIVITY	Boswellia carteri (BURSERACEAE)
77021	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Boswellia carteri (BURSERACEAE)
870238	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
1097115	EFFECTS DUE TO A COMBINATION OF DRUGSANTIFERTILITYPHARMACOLOGY OF EXTRACT - IN HUMANS	ABORTIFACIENT EFFECT	Boswellia carteri (BURSERACEAE)
848375	GC DATA REPORTEDPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL:
665585	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTATHIONE FORMATION INDUCTION	Boswellia carteri (BURSERACEAE)
665590	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTATHIONE FORMATION INDUCTION	Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL-11-KETO:
540183	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET ACTIVATING FACTOR BINDING INHIBITION	Boswellia carteri (BURSERACEAE)
299202	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,ALPHA: ACETYL:
870249	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	OCIMENE,BETA: CIS:
1048823	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Boswellia carteri (BURSERACEAE)
495323	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	MYRCENE
468635	IDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CINEOL,1-8:
870233	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
392355	AGRONOMIC STUDIES REPORTED		Boswellia carteri (BURSERACEAE)
21017	MEDICINAL FOLKLORE REPORTED FOR	DIURETIC ACTIVITY	Boswellia carteri (BURSERACEAE)
870244	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	GERANIOL ACETATE
1318406	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
1202434	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Boswellia carteri (BURSERACEAE)
284883	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE,5: INHIBITION	Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 9-11-DEHYDRO: 3-O-ACETYL:
779664	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Boswellia carteri (BURSERACEAE)
1320018	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
369945	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
546850	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
384815	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Boswellia carteri (BURSERACEAE)
21012	ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
1323560	TRADITIONAL MEDICINEPHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
870251	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PINENE,BETA:
1118006	PHARMACOLOGY OF EXTRACT - IN VIVO	PHAGOCYTOSIS STIMULATION	Boswellia carteri (BURSERACEAE)
779662	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
1147593	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICOAGULANT ACTIVITY	Boswellia carteri (BURSERACEAE)
1118007	PHARMACOLOGY OF EXTRACT - IN VIVO	PHAGOCYTOSIS STIMULATION	Boswellia carteri (BURSERACEAE)
16825	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	INCENSOLE OXIDE,ISO:
1318402	MEDICINAL FOLKLORE REPORTED FOR	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
21014	MEDICINAL FOLKLORE REPORTED FOR	ANTITREPONEMAL ACTIVITY	Boswellia carteri (BURSERACEAE)
16809	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	INCENSOLE OXIDE
1306371	MEDICINAL FOLKLORE REPORTED FOR	ANTIHYPERLIPEMIC ACTIVITY	Boswellia carteri (BURSERACEAE)
1190712	MEDICINAL FOLKLORE REPORTED FOR	ANTIBURN EFFECT	Boswellia carteri (BURSERACEAE)
870239	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Boswellia carteri (BURSERACEAE)
870254	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINENE,GAMMA:
870260	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	INCENSOLE,ISO:
468638	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	MUUROLENE,ALPHA:
1306370	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
791384	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	CYCLOOXYGENASE INHIBITION	Boswellia carteri (BURSERACEAE)
468633	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PHELLANDRENE,ALPHA:
870256	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINEOL,ALPHA:
1306376	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SUPPRESSION	Boswellia carteri (BURSERACEAE)	MENTH-4-EN,PARA-1,2-DIOL:SOBREROL,TRANS: (-):OLIBANUMOL BMENTH-1-EN,PARA-3,6-DIHYDROXY:OLIBANUMOL COLIBANUMOL AMENTH-5-EN,PARA-1,2-DIOL:FOUQUIEROL,ISO:LUPEOL,EPI:MENTH-1-EN,PARA-4-ALPHA,6-BETA-DIOL:
870267	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	HEXAN-1-OL ACETATE
714269	AROMATHERAPY STUDY		Boswellia carteri (BURSERACEAE)
73357	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Boswellia carteri (BURSERACEAE)
1320023	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIOXYTOCIC EFFECT	Boswellia carteri (BURSERACEAE)
593576	VOUCHER SPECIMEN REPORTED FOR		Boswellia carteri (BURSERACEAE)
468630	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	SABINENE
495325	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PHELLANDRENE,ALPHA:
639197	PHARMACOLOGY OF EXTRACT - IN VITRO	TESTOSTERONE-5-ALPHA-REDUCTASE INHIBITION	Boswellia carteri (BURSERACEAE)
870265	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	HEXAN-1-OL HEXANOATE
962216	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Boswellia carteri (BURSERACEAE)
702074	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HEPATITIS C VIRUS) INHIBITION	Boswellia carteri (BURSERACEAE)
77022	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Boswellia carteri (BURSERACEAE)
1147592	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTICOAGULANT ACTIVITY	Boswellia carteri (BURSERACEAE)
756000	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPOXYGENASE STIMULATION	Boswellia carteri (BURSERACEAE)
870257	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINOLENE
21011	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Boswellia carteri (BURSERACEAE)
284882	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 9-11-DEHYDRO: 3-O-ACETYL:
495324	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	TERPINEOL,ALPHA:
1306369	MEDICINAL FOLKLORE REPORTED FOR	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
870268	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	OCTAN-1-OL
280730	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Boswellia carteri (BURSERACEAE)	LUP-20(29)-EN-24-OIC ACID,3-ALPHA-ACETOXY:
848376	UV SPECTRUM GIVEN FORGC DATA REPORTEDPMR SPECTRUM REPORTEDHPLC DATA REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: 11-KETO:
724764	ISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA:BOSWELLIC ACID,ALPHA:
962215	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOGLYCEMIC ACTIVITY	Boswellia carteri (BURSERACEAE)
665588	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTATHIONE FORMATION INDUCTION	Boswellia carteri (BURSERACEAE)
665586	PHARMACOLOGY OF EXTRACT - IN VIVO	NUCLEOSIDE TRANSPORT INHIBITION	Boswellia carteri (BURSERACEAE)
870243	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	CYMENE,PARA:
779663	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Boswellia carteri (BURSERACEAE)
1320017	MEDICINAL FOLKLORE REPORTED FOR	ANALGESIC ACTIVITY	Boswellia carteri (BURSERACEAE)
69632	EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
870232	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
299199	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,BETA: ACETYL:
1306375	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SUPPRESSION	Boswellia carteri (BURSERACEAE)	OLIBANUMOL HOLIBANUMOL I
755999	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPOXYGENASE,5: INHIBITION	Boswellia carteri (BURSERACEAE)
16826	ISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	INCENSOLEINCENSOLE OXIDE
1318403	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
870250	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PINENE,ALPHA:
870235	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Boswellia carteri (BURSERACEAE)
870264	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	DECAN-1-OL ACETATE
495320	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	PINENE,ALPHA:
870246	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Boswellia carteri (BURSERACEAE)	LINALOOL
299200	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,ALPHA:
546851	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Boswellia carteri (BURSERACEAE)
848372	GC DATA REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAASSAY FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Boswellia carteri (BURSERACEAE)	BOSWELLIC ACID,ALPHA:

Experiments for taxon Boswellia carteri (BURSERACEAE)

Experiments (187 results)

Filters

Worktypes (27)

Pharmacology (46)

Compounds (69)

Organisms (55)